Suvd J, Gerel B, Otgooloi H, Purevsuren D, Zolzaya H, Roglic G, King H
Department of Endocrinology, National Medical University of Mongolia, Ulaanbaatar, Mongolia.
Diabet Med. 2002 Jun;19(6):502-8. doi: 10.1046/j.1464-5491.2002.00737.x.
Prevalence of glucose intolerance-diabetes and impaired glucose tolerance (IGT)-and of related conditions such as obesity and hypertension, was studied in six population samples in Mongolia in 1999.
Diagnosis of glucose intolerance was made on the basis of 2-h blood glucose concentration, according to criteria recommended by the latest report of a WHO Expert Group.
Crude prevalence of diabetes was 2.9% (2.6% in men and 3.2% in women). Prevalence of IGT was 10.2% (9.3% in men and 10.8% in women). Age standardization to the standard world population of Segi resulted in a total sample prevalence of 3.1% for diabetes and 9.2% for IGT. Prevalence of abnormal glucose tolerance differed according to district of residence. Approximately one-third of the subjects with diabetes were diagnosed prior to the survey. Of those who were diagnosed previously, approximately one-half were not under any form of treatment. Subjects with abnormal glucose tolerance were older, more obese and had higher blood pressure and prevalence of hypertension than those with normoglycaemia. One-half of men and almost one-half of women were hypertensive. Three-quarters of the diabetic subjects were hypertensive. One-third of all subjects were centrally obese. Considering the conditions of principal interest-glucose intolerance, hypertension and obesity-one-half of all subjects demonstrated one or more of these conditions. Central obesity was the most common condition, followed by hypertension and then glucose intolerance. Central obesity and hypertension was the most common combination (17% of all subjects) and 4% exhibited all three conditions.
Non-communicable diseases are already a threat to public health in Mongolia. Although the prevalence of diabetes is not high by international standards, the relatively high prevalence of IGT suggests that the situation may deteriorate in the future in the absence of concerted action to prevent and control diabetes and related conditions.
1999年对蒙古六个群体样本中的葡萄糖耐量异常-糖尿病、糖耐量受损(IGT)以及肥胖和高血压等相关病症的患病率进行了研究。
根据世界卫生组织专家小组最新报告推荐的标准,基于2小时血糖浓度对葡萄糖耐量异常进行诊断。
糖尿病的粗患病率为2.9%(男性为2.6%,女性为3.2%)。IGT的患病率为10.2%(男性为9.3%,女性为10.8%)。按照Segi世界标准人口进行年龄标准化后,糖尿病的总样本患病率为3.1%,IGT为9.2%。葡萄糖耐量异常的患病率因居住地区而异。约三分之一的糖尿病患者在调查前已被诊断。在那些先前已被诊断的患者中,约一半未接受任何形式的治疗。葡萄糖耐量异常的患者比血糖正常的患者年龄更大、更肥胖,血压更高且高血压患病率更高。一半的男性和近一半的女性患有高血压。四分之三的糖尿病患者患有高血压。三分之一的所有受试者为中心性肥胖。考虑到主要关注的病症——葡萄糖耐量异常、高血压和肥胖——一半的所有受试者表现出这些病症中的一种或多种。中心性肥胖是最常见的病症,其次是高血压,然后是葡萄糖耐量异常。中心性肥胖和高血压是最常见的组合(占所有受试者的17%),4%的受试者表现出所有三种病症。
非传染性疾病已对蒙古的公共卫生构成威胁。尽管按照国际标准糖尿病的患病率不高,但IGT相对较高的患病率表明,在缺乏预防和控制糖尿病及相关病症的协同行动的情况下,未来情况可能会恶化。